From January 1, 2024 to March 31, 2024, the company has repurchased 12,971,308 shares, representing 2.43% for CNY 147.82 million. With this, the company has completed the repurchase of 20,172,808 shares, representing 3.79% for CNY 243.66 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.96 CNY | -0.99% | -5.08% | -33.28% |
May. 10 | ChenGuang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 24 | ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.28% | 634M | |
-1.69% | 277B | |
-5.38% | 91.92B | |
-4.35% | 42.95B | |
+0.99% | 41.25B | |
+6.11% | 40.01B | |
+5.54% | 38.81B | |
-13.54% | 30.87B | |
-11.43% | 27.21B | |
+9.17% | 24.19B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.